Università Cattolica del Sacro Cuore, Rome, Italy.
Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea; Gastric Cancer Center, Yonsei Cancer Center, Yonsei University Health System, Seoul, Republic of Korea.
Eur J Surg Oncol. 2024 Jun;50(6):108359. doi: 10.1016/j.ejso.2024.108359. Epub 2024 Apr 19.
Peritoneal recurrence is a significant cause of treatment failure after radical gastrectomy for gastric cancer. The prediction of metachronous peritoneal recurrence would have a significantly impact risk stratification and tailored treatment planning. This study aimed to externally validate the previously established PERI-Gastric 1 and 2 models to assess their generalizability in an independent population.
Retrospective external validation was conducted on a cohort of 8564 patients who underwent elective gastrectomy for stage Ib-IIIc gastric cancer between 1998 and 2018 at the Yonsei Cancer Center. Discrimination was tested using the area under the receiver operating characteristic curves (AUROC). Accuracy was tested by plotting observations against the predicted risk of peritoneal recurrence and analyzing the resulting calibration plots. Clinical usefulness was tested with a decision curve analysis.
In the validation cohort, PERI-Gastric 1 and PERI-Gastric 2 exhibited an AUROC of 0.766 (95 % C.I. 0.752-0.778) and 0.767 (95 % C.I. 0.755-0.780), a calibration-in-the-large of 0.935 and 0.700, a calibration belt with a 95 % C.I. over the bisector in the risk range of 24%-33 % and 35%-47 %. The decision curve analysis revealed a positive net benefit in the risk range of 10%-42 % and 15%-45 %, respectively.
This study presents the external validation of the PERI-Gastric 1 and 2 scores in an Eastern population. The models demonstrated fair discrimination and satisfactory calibration for predicting the risk of peritoneal recurrence after radical gastrectomy, even in Eastern patients. PERI-Gastric 1 and 2 scores could also be applied to predict the risk of metachronous peritoneal recurrence in Eastern populations.
腹膜复发是胃癌根治性胃切除术后治疗失败的一个重要原因。对异时性腹膜复发的预测将对风险分层和针对性治疗计划产生重大影响。本研究旨在对先前建立的 PERI-Gastric 1 和 2 模型进行外部验证,以评估其在独立人群中的通用性。
对 1998 年至 2018 年在延世癌症中心接受择期胃癌根治术的 8564 例 Ib-IIIc 期胃癌患者的队列进行回顾性外部验证。使用接收者操作特征曲线下面积(AUROC)来测试区分度。通过绘制观测值与腹膜复发预测风险的关系图,并分析由此产生的校准图来测试准确性。通过决策曲线分析来测试临床实用性。
在验证队列中,PERI-Gastric 1 和 PERI-Gastric 2 的 AUROC 分别为 0.766(95%CI 0.752-0.778)和 0.767(95%CI 0.755-0.780),大校准率为 0.935 和 0.700,校准带在 24%-33%和 35%-47%的风险范围内,95%CI 在二分线以上。决策曲线分析显示,在 10%-42%和 15%-45%的风险范围内,分别存在正净获益。
本研究在东亚人群中进行了 PERI-Gastric 1 和 2 评分的外部验证。这些模型在预测根治性胃切除术后腹膜复发风险方面表现出良好的区分度和令人满意的校准度,即使在东亚患者中也是如此。PERI-Gastric 1 和 2 评分也可应用于预测东亚人群的异时性腹膜复发风险。